Medplus Health (MEDPLUS) | Stock Overview & Key Data
Medplus Health Performance Comparison
Stock Range
Today's Range
Low: ₹805.35
High: ₹829.60
on August 14, 2025
52 Week Range
Low: ₹616.00
High: ₹1,045.30
on August 26, 2024
on May 28, 2025
All-Time High: ₹1,343.00 on January 17, 2022
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR96.4B
EPS
14.83
P/E Ratio (TTM)
54.22
Forward P/E
53.18
P/B Ratio
5.49
PEG Ratio
53.18
Div. Yield
N/A
ROE
8.64%
Beta
0.685
Debt to Equity
64.36
Financial Highlights
Profitability
Gross Margin
26.12%
Operating Margin
4.22%
Profit Margin
2.88%
Returns and Earnings
Return on Assets (TTM)
4.47%
Return on Equity (TTM)
8.64%
EBITDA
INR5.8B
Net Income (TTM)
INR1.8B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR517.38
Quarterly Revenue Growth (YoY)
3.60%
Quarterly Earnings Growth (YoY)
194.90%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Medplus Health MEDPLUS | 96.37B Mid-cap | -3.02% | -7.43% | -0.80% | 12.29% | -4.09% | 26.72% | 13.27% | -24.37% |
| Sastasundar Ventures SASTASUNDR | 8.64B Small-cap | -3.53% | -1.18% | 3.11% | -1.68% | -14.54% | -12.63% | -3.96% | 160.73% |
| Trident Lifeline TLL | 3.21B Small-cap | 0.65% | 3.67% | -4.88% | 4.85% | -2.54% | -1.27% | 117.78% | 117.78% |
| One Global Service ONEGLOBAL | 1.92B Small-cap | 20.97% | 21.44% | 22.95% | 2.07% | -13.34% | 110.07% | 618.11% | 6,634.45% |
| Murae Organisor MURAE | 1.27B Small-cap | -12.68% | -27.06% | -7.46% | -22.50% | -36.73% | 8.77% | -46.09% | -81.71% |
| Achyut Healthcare ACHYUT | 1.17B Small-cap | 14.25% | 31.85% | 48.53% | 19.67% | 21.69% | -89.65% | -74.10% | -74.10% |
Ownership & Short Interest
Insider Ownership
41.82%
Institutional Ownership
34.53%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
358K
Average 90-Day Volume
202K
Medplus Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Medplus Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MEDPLUS's 52-week high and low?
- In the last 52 weeks, Medplus Health reached a high of ₹1,045.30 (on May 28, 2025) and a low of ₹616.00 (on August 26, 2024).
- What is the market cap and P/E ratio for MEDPLUS?
- Curious about Medplus Health's size and valuation? Its market capitalization stands at 96.37B. When it comes to valuation, the P/E ratio (trailing twelve months) is 54.22, and the forward P/E (looking ahead) is 53.18.
- Does MEDPLUS pay dividends? If so, what's the yield?
- As for dividends, Medplus Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Medplus Health's main competitors or similar companies to consider before investing?
When looking at Medplus Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sastasundar Ventures
SASTASUNDR8.64B Healthcare Pharmaceutical Retailers -12.63% -3.96% Trident Lifeline
TLL3.21B Healthcare Pharmaceutical Retailers -1.27% 117.78% One Global Service
ONEGLOBAL1.92B Healthcare Pharmaceutical Retailers 110.07% 618.11% Murae Organisor
MURAE1.27B Healthcare Pharmaceutical Retailers 8.77% -46.09% Achyut Healthcare
ACHYUT1.17B Healthcare Pharmaceutical Retailers -89.65% -74.10% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medplus Health Services Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Medplus Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.64%, the Debt to Equity ratio from the most recent quarter is 64.36, and its Gross Profit Margin stands at 26.12%.
- What is the recent revenue and earnings growth for MEDPLUS?
- Looking at Medplus Health's growth, its revenue over the trailing twelve months (TTM) was INR62B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.60%, and quarterly earnings saw a YoY growth of 194.90%.
- How much of MEDPLUS stock is held by insiders and institutions?
- Wondering who owns Medplus Health stock? Company insiders (like executives and directors) hold about 41.82% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 34.53%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.